Search Results

Not Found

Not Found

The provided text is an FDA 510(k) clearance letter for a "Ceradium Non-Precious Ceramic Alloy." This type of document does not contain details about acceptance criteria or a study proving device performance in the way a medical device efficacy or AI performance study report would.

The letter explicitly states: "We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976..."

This means the device was cleared based on its substantial equivalence to a previously legally marketed device, not on a new clinical study demonstrating specific performance metrics against pre-defined acceptance criteria. The FDA's 510(k) process for this type of device typically relies on demonstrating that the new device has "the same intended use as the predicate device" and "the same technological characteristics as the predicate device" or "different technological characteristics from the predicate device" but that "the new device does not raise different questions of safety and effectiveness than the predicate device" and "the new device is as safe and effective as the predicate device."

Therefore, I cannot extract the requested information (acceptance criteria, study details, sample sizes, expert qualifications, etc.) from this document because it is not present. This document is a regulatory approval letter, not a device performance study report.

Ask a specific question about this device